(VIANEWS) – AMSC (AMSC.OL), NAVAMEDIC (NAVA.OL), KONGSBERG GRUPPEN (KOG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. AMSC (AMSC.OL)
1395% sales growth and 8.21% return on equity
AMSC ASA, through its subsidiaries, operates as a ship owning and lease finance company in the United States. The company purchases and bareboat charters out vessels to operators and end users. It operates a fleet of nine product tankers, one shuttle tanker, and one subsea construction vessel. The company was formerly known as American Shipping Company ASA and changed its name to AMSC ASA in October 2022. AMSC ASA was founded in 2005 and is headquartered in Lysaker, Norway.
Earnings Per Share
As for profitability, AMSC has a trailing twelve months EPS of kr2.08.
PE Ratio
AMSC has a trailing twelve months price to earnings ratio of 21.85. Meaning, the purchaser of the share is investing kr21.85 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.
Sales Growth
AMSC’s sales growth is 1367.3% for the ongoing quarter and 1395% for the next.
Yearly Top and Bottom Value
AMSC’s stock is valued at kr45.45 at 22:20 EST, below its 52-week high of kr48.80 and way higher than its 52-week low of kr34.15.
More news about AMSC.
2. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 34.49. Meaning, the purchaser of the share is investing kr34.49 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Sales Growth
NAVAMEDIC’s sales growth is 22.8% for the current quarter and 17.3% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 454.46M for the twelve trailing months.
Moving Average
NAVAMEDIC’s worth is way above its 50-day moving average of kr36.13 and way above its 200-day moving average of kr36.95.
Volume
Today’s last reported volume for NAVAMEDIC is 9138 which is 78.93% below its average volume of 43386.
More news about NAVAMEDIC.
3. KONGSBERG GRUPPEN (KOG.OL)
11.2% sales growth and 26.05% return on equity
Kongsberg Gruppen ASA, together with its subsidiaries, provides high-tech systems and solutions primarily to customers in the maritime and defense markets. The company operates through three segments: Kongsberg Maritime, Kongsberg Defence & Aerospace, and Other. The Kongsberg Maritime segment offers solutions and systems for bridge and control systems, which include dynamic positioning, propulsion control, and navigation, as well as automation systems; energy solutions and ship design services; and propellers, thrusters, water jet systems, and systems for offshore manoeuvring of maritime vessels. This segment also provides winches for mooring, anchor handling, and special systems for offshore vessels, tugs, marine vessels, and various other classes of vessel, as well as cranes; hydroacoustics; autonomous underwater vessels and solutions for autonomous maritime vessels; and products related to fisheries, systems for underwater mapping, and sensors and solutions for specialist vessels. The Kongsberg Defence & Aerospace segment offers various systems and services to the defense industry. It provides air defense and combat systems, sonars, and navigation for marine vessels and submarines, as well as integrated command and control systems; remote tower solutions for airports; remote control weapon stations for land-based vehicles and marine vessels; products for military tactical communication; naval strike and air-to-surface missiles; and lightweight composite and titanium components for F-35 combat aircraft. This segment also offers components and services to the space industry, as well as port monitoring systems; and maintenance, repair, and overhaul services. The Other segment focuses on digitalization within the oil and gas, wind, and merchant marine markets. It operates primarily in Norway, Europe, North America, South America, Asia, Australia, and Africa. Kongsberg Gruppen ASA was founded in 1814 and is headquartered in Kongsberg, Norway.
Earnings Per Share
As for profitability, KONGSBERG GRUPPEN has a trailing twelve months EPS of kr19.11.
PE Ratio
KONGSBERG GRUPPEN has a trailing twelve months price to earnings ratio of 24.63. Meaning, the purchaser of the share is investing kr24.63 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.05%.
More news about KONGSBERG GRUPPEN.
